Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- BioStem Technologies, Inc.
- Merck & Co.
Comparative performance (base 100)
Each asset is worth 100 at October 13, 2025; a value of 120 means +20% since that date (latest common date: October 12, 2026).
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | BioStem Technologies, Inc.Stock | Merck & Co.Stock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | −40.8% | +69.7% |
| Annualized performanceAverage annual return that would produce the same total performance. | −40.9% | +70.0% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 118.6% | 29.2% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −70.9% | −11.9% |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 0.09 | 2.48 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −10.3% | −2.4% |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 46.12M $ | 359.22B $ |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 2.8 | 115.6 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 1.3 | 5.4 |
| Net marginShare of revenue retained as profit. | −81.8% | 4.8% |
| Return on equityReturn on equity (ROE). | −74.7% | 7.0% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | −27.9% | +5.1% |
| Dividend yieldAnnual dividend relative to the share price. | None | 2.39% |
| Debt / equityFinancial debt relative to shareholders' equity. | 4% | 128% |
Correlations over the period
From −1 to 1: close to 1, the two assets rise and fall together; close to 0, they move independently.
- BioStem Technologies, Inc. / Merck & Co.-0.05
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.